Sorry, let me rephrase my question.
How does SM6 compare to some of the other antibodies in clinical phase for the treatment of MM? Why would Onyx choose SM6 over any of the other antibodies?
The tablet below is a list of Antibodies in development/clinical study for the Tx of MM.
Reference (informative reading material): http://www.klinikum.uni-heidelberg.de/fileadmin/medizinische_klinik/Abteilung_5/images/Veranstaltungen/MM_Workshop_2013/Samstag/Raab_HMW2013.pdf
- Forums
- ASX - By Stock
- PAB
- why onyx sees the opportunity - deja vu ?
PAB
patrys limited
Add to My Watchlist
0.00%
!
0.2¢

why onyx sees the opportunity - deja vu ?, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.731M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
60 | 187900723 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 56113802 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
56 | 183826224 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 55948802 | 23 |
0.003 | 16007966 | 11 |
0.004 | 700000 | 1 |
0.005 | 500000 | 1 |
0.006 | 300000 | 1 |
Last trade - 16.21pm 25/07/2025 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online